Table 1.
Metabolic engineering strategies | Beneficial effect for 3-HP production | Reference |
---|---|---|
Increasing the supply of malonyl-CoA: Overexpression the enzymes (ALD6, ACSse, ADH2) for acetyl-CoA accumulation; Deleting the MLS1 to block the consumption of acetyl-CoA; Overexpression the ACC1 catalyzing acetyl-CoA to malonyl-CoA. Increasing the supply of NADPH: Overexpression the GAPN catalyzing the formation of extra NADPH. Establishing the MCR pathway: Overexpression the CaMCR. | 3-HP production was increased to 463 mg/L | Chen et al., 2014 |
Generating the ACC1 mutant (ACC1Ser659Ala Ser1157Ala) through mutating the potential phosphorylation sites to abolish the post-translational regulation Increasing the ACC1 activity by overexpression of the ACC1 mutant | 3-HP production was up to ∼2.2-fold more than that of the wild-type ACC1 | Shi et al., 2014 |
Constructing the β-alanine pathway by overexpressing AAT2, PYC1, PYC2, ALT, BcBAPAT, EcHPDH, and multiple copies of TcPAND | 13.7 g/L 3-HP was generated through the constructed β-alanine pathway from glucose in fed-batch fermentation at low pH. | Borodina et al., 2015 |
Increasing the supply of acetyl-CoA by overexpressing PDC1, ALD6, and ACSse; Engineering the cofactor specificity of the GAPN to increase the production of NADPH at the expense of NADH and thus improve 3-HP production and reduce formation of glycerol as by-product; Integrating multiple copies of CaMCR and ACC1 mutant genes into the genome. | 3-HP was produced at a titer 7.37 g/L in a carbon-limited fed-batch fermentation | Kildegaard et al., 2016 |
Developing a malonyl-CoA biosensor based on the bacterial transcription factor FapR to monitor and precisely control the intracellular malonyl-CoA concentration | 3-HP titer was enhanced i by 120% | Li et al., 2015 |
A hierarchical dynamic control strategy to control the expression level of CaMCR depending on the intracellular malonyl-CoA concentration: The upper level of control was to dynamically downregulate fatty acid biosynthesis using HXT1 promoter. The lower level was based on the malonyl-CoA biosensor. | 3-HP production was increased by 10-fold | David et al., 2016 |
Improving the availability of malonyl-CoA through down-regulating lipid synthesis. Manipulating the phospholipid synthesis transcriptional regulators including Ino2p, Ino4p, Opi1p, and a series of synthetic Ino2p variants, combining with studying the inositol and choline effect. | 3-HP production was increased by 9-fold | Chen et al., 2017 |
Identifying and characterizing promoters that depend on glucose concentration for use as dynamic control elements. Identifying 34 candidate promoters that strongly responded to glucose presence or absence. A subset of promoters, pADH2, pICL1, and pHXT7, were demonstrated as suitable for dynamic control of 3-HP production. | Regulating the 3-HP pathway by the ICL1 promoter resulted in 70% improvement of 3-HP titer in comparison to PGK1 promoter. | Maury et al., 2018 |
AAT2, aspartate aminotransferase 2; ACC1, acetyl-CoA carboxylase; ACSse, acetylation-insensitive acetyl-CoA synthetase from Salmonella enterica; ADH2, alcohol dehydrogenase; ALD6, NADP-dependent aldehyde dehydrogenase; ALT, alanine aminotransferase; BcBAPAT, β-alanine-pyruvate aminotransferase from Bacillus cereus; EcHPDH, 3-hydroxypropionate dehydrogenase from E. coli; GAPN, NADP-dependent G3P dehydrogenase; CaMCR, malonyl-CoA reductase from Chloroflexus aurantiacus; MLS1, cytosolic malate synthase; PDC1, pyruvate decarboxylase; PYC1/2, pyruvate carboxylase 1/2; TcPAND, aspartate decarboxylase from Tribolium castaneum.